Radiopharmaceuticals: US FDA Guidance Allows Some Flexibility For Burgeoning Drug Class

 
• By Manas Mishra
  
Team Of Medical Research Scientists Collectively Working
The draft guidance arrives as the number of radiopharmaceutical therapy trials grows. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D